急性缺血性卒中血管内治疗成功再灌注后梗死体积仍增长:一项荟萃分析
该系统综述与荟萃分析纳入10项研究共973例血管内治疗后达到成功再灌注(TICI 2b-3)的急性卒中患者,基线平均梗死体积19.5 mL,最终平均梗死体积37.5 mL,合并平均梗死增长14.8 mL(95% CI,7.9-21.7 mL);荟萃回归显示基线梗死体积更高、不完全再灌注(改良TICI 2b)比例更高及发病至再灌注时间更长的研究梗死增长更高。
要点
- 成功再灌注(TICI 2b-3)后梗死体积仍平均增长14.8 mL(95% CI,7.9-21.7 mL)。
- 基线平均梗死体积19.5 mL,最终平均梗死体积37.5 mL。
- TICI 2b再灌注占24%,TICI 2c或3占76%。
核心结论
- 血管内治疗成功再灌注后仍存在相当程度的梗死增长,作者呼吁加快工作流程并需要特异性治疗以限制梗死增长。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE和Google Scholar至2020年10月31日,纳入10项报告MR成像基线与血管内治疗后梗死体积的研究共973例TICI 2b-3患者。
诊断标准与关键数值
- 成功再灌注定义为TICI 2b-3;TICI 2b再灌注grade占24%,TICI 2c或3占76%;合并平均梗死增长14.8 mL(95% CI,7.9-21.7 mL)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 研究间存在显著异质性,可能由早期与晚期治疗研究之间梗死增长的差异驱动。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Infarct volume inversely correlates with good recovery in stroke. The magnitude and predictors of infarct growth despite successful reperfusion via endovascular treatment are not known.
PURPOSE: We aimed to summarize the extent of infarct growth in patients with acute stroke who achieved successful reperfusion (TICI 2b-3) after endovascular treatment.
DATA SOURCES: We performed a systematic review and meta-analysis by searching MEDLINE and Google Scholar for articles published up to October 31, 2020.
STUDY SELECTION: Studies of >10 patients reporting baseline and post-endovascular treatment infarct volumes on MR imaging were included. Only patients with TICI 2b-3 were included. We calculated infarct growth at a study level as the difference between baseline and follow-up MR imaging infarct volumes.
DATA ANALYSIS: Our search yielded 345 studies, and we included 10 studies reporting on 973 patients having undergone endovascular treatment who achieved successful reperfusion.
DATA SYNTHESIS: The mean baseline infarct volume was 19.5 mL, while the mean final infarct volume was 37.5 mL. A TICI 2b reperfusion grade was achieved in 24% of patients, and TICI 2c or 3 in 76%. The pooled mean infarct growth was 14.8 mL (95% CI, 7.9-21.7 mL). Meta-regression showed higher infarct growth in studies that reported higher baseline infarct volumes, higher rates of incomplete reperfusion (modified TICI 2b), and longer onset-to-reperfusion times.
LIMITATIONS: Significant heterogeneity among studies was noted and might be driven by the difference in infarct growth between early- and late-treatment studies.
CONCLUSIONS: These results suggest considerable infarct growth despite successful endovascular treatment reperfusion and call for a faster workflow and the need for specific therapies to limit infarct growth.
引用
- Bala F, Ospel J, Mulpur B, et al. Infarct Growth despite Successful Endovascular Reperfusion in Acute Ischemic Stroke: A Meta-analysis. AJNR Am J Neuroradiol. 2021. PMID: 34083260. doi:10.3174/ajnr.A7177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。